ER
CVS icon

Enlightenment Research’s CVS Health CVS Stock Holding History

Enlightenment Research’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-3,799
Closed -$352K – 105
2022
Q2 		$352K Buy
+3,799
New +$371K 0.76% 44
2021
Q1 		– Sell
-5,300
Closed -$362K – 150
2020
Q4 		$362K Buy
+5,300
New +$345K 0.51% 51
2019
Q3 		– Sell
-7,300
Closed -$398K – 138
2019
Q2 		$398K Sell
7,300
-8,596
-54% -$463K 0.2% 137
2019
Q1 		$857K Sell
15,896
-3,299
-17% -$204K 1.67% 15
2018
Q4 		$1.26M Buy
+19,195
New +$1.43M 1.56% 8

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Enlightenment Research's CVS Position: Q3 2022 in Review

Enlightenment Research sold out of CVS Health (CVS) in Q3 2022, closing a stake of 3,799 shares — an estimated $352K sold.

Enlightenment Research first reported a position in CVS in Q4 2018 and held it in 5 quarters. The position peaked at $1.26M in Q4 2018. 2,325 funds tracked by Wall St. Rank hold CVS as of Q3 2022.

  • Enlightenment Research reported no remaining CVS Health position as of Q3 2022 after selling out during the quarter.
  • Enlightenment Research sold 3,799 CVS Health shares in Q3 2022, an estimated $352K.
  • Enlightenment Research first reported a position in CVS Health in Q4 2018 and held it in 5 quarters.
  • Enlightenment Research's CVS Health position peaked at $1.26M in Q4 2018.
  • 2,325 funds tracked by Wall St. Rank held CVS Health as of Q3 2022.

Based on Enlightenment Research's 13F filing for Q3 2022, filed 15 Nov 2022.